Literature DB >> 24789115

Long-term clinical course of Glut1 deficiency syndrome.

Aliza S Alter1, Kristin Engelstad1, Veronica J Hinton2, Jacqueline Montes1, Toni S Pearson1, Cigdem I Akman1, Darryl C De Vivo3.   

Abstract

Our objective is to characterize the long-term course of Glut1 deficiency syndrome. Longitudinal outcome measures, including Columbia Neurological Scores, neuropsychological tests, and adaptive behavior reports, were collected for 13 participants with Glut1 deficiency syndrome who had been followed for an average of 14.2 (range = 8.9-23.6) years. A parent questionnaire assessed manifestations throughout development. The 6-Minute Walk Test captured gait disturbances and triggered paroxysmal exertional dyskinesia. All longitudinal outcomes remained stable over time. Epilepsy dominated infancy and improved during childhood. Dystonia emerged during childhood or adolescence. Earlier introduction of the ketogenic diet correlated with better long-term outcomes on some measures. Percent-predicted 6-Minute Walk Test distance correlated significantly with Columbia Neurological Scores. We conclude that Glut1 deficiency syndrome is a chronic condition, dominated by epilepsy in infancy and by movement disorders thereafter. Dietary treatment in the first postnatal months may effect improved outcomes, emphasizing the importance of early diagnosis and treatment.
© The Author(s) 2014.

Entities:  

Keywords:  Glut1 deficiency syndrome; epilepsy; genetics; movement disorders; neurometabolic disorders

Mesh:

Substances:

Year:  2014        PMID: 24789115     DOI: 10.1177/0883073814531822

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  22 in total

1.  Paroxysmal ocular movements - an early sign in Glut1 deficiency Syndrome.

Authors:  Sofia Reis; Joana Matias; Raquel Machado; José Paulo Monteiro
Journal:  Metab Brain Dis       Date:  2018-05-05       Impact factor: 3.584

Review 2.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

3.  Treatment of paroxysmal dyskinesias in children.

Authors:  Jonathan W Mink
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

Review 4.  Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features.

Authors:  Serena Galosi; Francesca Nardecchia; Vincenzo Leuzzi
Journal:  Mov Disord Clin Pract       Date:  2020-02-04

5.  CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome.

Authors:  Emanuele Barca; Maoxue Tang; Giulio Kleiner; Kristin Engelstad; Salvatore DiMauro; Catarina M Quinzii; Darryl C De Vivo
Journal:  JIMD Rep       Date:  2015-11-29

6.  βOHB Protective Pathways in Aralar-KO Neurons and Brain: An Alternative to Ketogenic Diet.

Authors:  Irene Pérez-Liébana; María José Casarejos; Andrea Alcaide; Eduardo Herrada-Soler; Irene Llorente-Folch; Laura Contreras; Jorgina Satrústegui; Beatriz Pardo
Journal:  J Neurosci       Date:  2020-10-21       Impact factor: 6.167

7.  Characterization of Speech and Language Phenotype in GLUT1DS.

Authors:  Martina Paola Zanaboni; Ludovica Pasca; Barbara Valeria Villa; Antonella Faggio; Serena Grumi; Livio Provenzi; Costanza Varesio; Valentina De Giorgis
Journal:  Children (Basel)       Date:  2021-04-27

8.  Paroxysmal eye-head movements in Glut1 deficiency syndrome.

Authors:  Toni S Pearson; Roser Pons; Kristin Engelstad; Steven A Kane; Michael E Goldberg; Darryl C De Vivo
Journal:  Neurology       Date:  2017-03-24       Impact factor: 9.910

9.  Genetic Identification in Early Onset Parkinsonism among Norwegian Patients.

Authors:  Emil K Gustavsson; Joanne Trinh; Marna McKenzie; Stephanie Bortnick; Maria Skaalum Petersen; Matthew J Farrer; Jan O Aasly
Journal:  Mov Disord Clin Pract       Date:  2017-05-23

Review 10.  Movement Disorders in Genetic Pediatric Ataxias.

Authors:  Simone Gana; Enza Maria Valente
Journal:  Mov Disord Clin Pract       Date:  2020-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.